Identification of patients and risk factors in chronic kidney disease--evaluating risk factors and therapeutic strategies.
about
Gene therapy by electroporation for the treatment of chronic renal failure in companion animalsChronic kidney disease and end-stage renal disease-a review produced to contribute to the report 'the status of health in the European union: towards a healthier Europe'.Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: A systematic review and meta-analysis based on observational cohort studiesEpoetin zeta in the management of anemia associated with chronic kidney disease, differential pharmacology and clinical utility.An integrated approach to care for patients with chronic kidney disease.Long-term renal outcomes in patients with traumatic brain injury: A nationwide population-based cohort study.Hemodialysis access usage patterns in the incident dialysis year and associated catheter-related complicationsRelationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CRISP cohortCommunity-based study on CKD subjects and the associated risk factors.Anemia, diabetes, and chronic kidney disease.Heat-processed Panax ginseng and diabetic renal damage: active components and action mechanism.Patient independence in chronic kidney disease and anaemia: implications of the 2012 KDIGO guideline.Estimating One-Year Risk of Incident Chronic Kidney Disease: Retrospective Development and Validation Study Using Electronic Medical Record Data From the State of Maine.Proteinuria causes dysfunctional autophagy in the proximal tubule.Long-term safety and tolerability of epoetin zeta, administered intravenously, for maintenance treatment of renal anemia.Independent Contributions of Obstructive Sleep Apnea and the Metabolic Syndrome to the Risk of Chronic Kidney Disease.Improvement in eGFR in patients with chronic kidney disease attending a nephrology clinic.Chronic kidney disease in patients at high risk of cardiovascular disease in the United Arab Emirates: A population-based study.
P2860
Q33400571-347C1F2D-084C-4767-BBBD-15E220510E47Q33816875-E8FDDF5F-A31F-4A58-8989-3FA810787A18Q34042891-499372B3-DD66-419F-AA6C-9CFDF8EC070DQ35162053-C770A081-D387-4C1F-AC40-E9ACA92531A0Q35217027-38BE6858-2976-4C34-82FD-2AF0B1DF25E6Q36280117-B1200E3F-416A-4916-BCA2-F2026FF93643Q36496021-72519699-D04F-45A6-B6C9-C6212C0EEA32Q36616057-1B07BEBA-5383-417C-B9A7-71567E30F8F7Q37231746-878DFCA6-D713-4471-BC98-847691470E89Q37235968-7D455342-25AD-4A69-AB0D-FCC5DC8A2435Q37303174-3DFD9548-34C1-4CAF-B098-A4A0414C809FQ38107560-64DCD276-5FF3-4EE1-A105-812C63F9CE31Q38659530-16F1BBA9-D442-4E9B-9E6B-421A6CFDAEBDQ38748756-9F0F16C9-BE55-4D73-8EAE-0A1521B9549DQ42600775-7C01A4E4-DA6C-47C4-BB96-71CB7AB33EC4Q47681527-B18D06AD-1051-479F-9B39-254CF6EE3A8DQ51708058-7F01529A-D6CF-48D0-A1A9-212E35A964B7Q55513336-22ACAF98-E35F-447C-A660-70163D5A654F
P2860
Identification of patients and risk factors in chronic kidney disease--evaluating risk factors and therapeutic strategies.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Identification of patients and ...... rs and therapeutic strategies.
@ast
Identification of patients and ...... rs and therapeutic strategies.
@en
Identification of patients and ...... rs and therapeutic strategies.
@nl
type
label
Identification of patients and ...... rs and therapeutic strategies.
@ast
Identification of patients and ...... rs and therapeutic strategies.
@en
Identification of patients and ...... rs and therapeutic strategies.
@nl
prefLabel
Identification of patients and ...... rs and therapeutic strategies.
@ast
Identification of patients and ...... rs and therapeutic strategies.
@en
Identification of patients and ...... rs and therapeutic strategies.
@nl
P356
P1476
Identification of patients and ...... rs and therapeutic strategies.
@en
P2093
P356
10.1093/NDT/16.SUPPL_7.57
P407
P478
16 Suppl 7
P577
2001-01-01T00:00:00Z